...
首页> 外文期刊>Diabetes/metabolism research and reviews >Role of elevated EGFR phosphorylation in the induction of structural remodelling and altered mechanical properties of resistance artery from type 2 diabetic mice.
【24h】

Role of elevated EGFR phosphorylation in the induction of structural remodelling and altered mechanical properties of resistance artery from type 2 diabetic mice.

机译:EGFR磷酸化升高在诱导2型糖尿病小鼠抵抗动脉的结构重构和改变机械特性中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Type 2 diabetes is associated with microvascular complications. We hypothesized that the sustained elevated EGFR phosphorylation produces structural wall remodelling and altered mechanical properties of mesenteric resistance artery (MRA) in type 2 diabetes. METHODS: Freshly isolated MRA (80-100 microm diameter) from type 2 diabetic (db(-)/db(-), diabetic) and non-diabetic (db(-)/db(+), control) mice were subjected to pressure-passive diameter and wall thickness relationships; western blot analysis and immunohistology. RESULTS: Data indicated that MRA from diabetic mice have a smaller passive diameter than MRA from control mice under intra-luminal pressure range from 25 to 125 mmHg. Measurements of wall thickness : lumen diameter ratios (21 +/- 1.8 vs 14 +/- 1.2 at 75 mmHg diabetic vs control, respectively), wall thickness and remodelling index (38 +/- 5% vs control) revealed eutrophic structural remodelling of MRA from diabetic mice, which was strengthened with histology. Mechanical properties revealed a great strain-stress relationship in MRA from control versus diabetic mice indicating increased stiffness in MRA from diabetic mice. Western blot analysis showed increased collagen type 1 content in a freshly isolated MRA from the type 2 diabetic mice when compared to control mice. Diabetic mice treated with EGFR inhibitor (AG1478, 10 mg/kg/day) for 2 weeks showed reduced EGFR phosphorylation, wall thickness, collagen type 1 content, and improved the altered mechanical properties of MRA. CONCLUSION: These data provide evidence regarding the role of EGFR in morphological wall remodelling and altered mechanical properties of MRA from type 2 diabetic mice. This may identify new therapeutic targets for the control of vascular structure and therefore have important implications in type 2 diabetes.
机译:背景:2型糖尿病与微血管并发症有关。我们假设持续的EGFR磷酸化水平升高会导致结构壁重塑,并改变2型糖尿病中肠系膜阻力动脉(MRA)的机械性能。方法:对新鲜分离的来自2型糖尿病(db(-)/ db(-),糖尿病)和非糖尿病(db(-)/ db(+),对照)小鼠的MRA(直径80-100微米)进行处理无源压力与壁厚的关系;免疫印迹分析和免疫组织学。结果:数据显示,在腔内压力范围为25至125 mmHg的情况下,糖尿病小鼠的MRA的被动直径小于对照组小鼠的MRA。壁厚的测量:糖尿病患者与对照组在75 mmHg时的管腔直径比(分别为21 +/- 1.8和14 +/- 1.2),壁厚和重塑指数(与对照组相比为38 +/- 5%)显示了富营养化的重塑来自糖尿病小鼠的MRA,在组织学上得到了加强。力学性能显示,与对照组相比,糖尿病小鼠的MRA具有很大的应变-应力关系,表明来自糖尿病小鼠的MRA的硬度增加。 Western印迹分析显示,与对照小鼠相比,来自2型糖尿病小鼠的新鲜分离MRA中1型胶原蛋白含量增加。用EGFR抑制剂(AG1478,10 mg / kg / day)治疗2周的糖尿病小鼠表现出降低的EGFR磷酸化,壁厚,1型胶原蛋白含量和改善的MRA力学性能。结论:这些数据提供了关于EGFR在2型糖尿病小鼠的形态学壁重塑和MRA改变的机械特性中的作用的证据。这可能会确定用于控制血管结构的新治疗靶标,因此在2型糖尿病中具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号